Vanguard Pharma announces major new business win with key pharmaceutical client to begin in Q3 2011
May 2, 2011 01:46 PM
Vanguard Pharma is pleased to announce that it has been selected by a major pharmaceutical company to manage a large national salesforce charged with launching a new cardiovascular product.
The two-year deal has both a fixed-fee and bonus revenue structure for Vanguard Pharma. Kevin Danylchuk, President and General Manager of Vanguard Pharma, announced, "We are thrilled to be selected for this important project. Our team and the client gelled exceptionally well with respect to a shared business approach and philosophies. We will work very hard to ensure the project is successful. The project is the largest in our history and is yet another sign that Vanguard is effectively taking the steps to serve our clients in the best way possible.”
To request more information about Vanguard Pharma, please visit out Contact Us page.